Ulcerative colitis: yet another paradoxical effect of tumour necrosis factor blockers?

E-ISSN： 1365-2133|178|2|333-334

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.178, Iss.2, 2018-02, pp. : 333-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Compassionate access anti‐tumour necrosis factor‐α therapy for ulcerative colitis in Australia: the benefits to patients

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 6, 2015-06 ,pp. : 659-666

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serology and ulcerative colitis behavior

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 1, 2015-01 ,pp. : 64-70

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk Factors for Tuberculosis in Patients Receiving Tumour Necrosis Factor-α Blockers: What Do We Really Know?

Respiration, Vol. 90, Iss. 3, 2015-0 ,pp. : 185-186

Karger

Access to resources Recommend Favorite

Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 551-555

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of mast cell granules on the gene expression of nitric oxide synthase and tumour necrosis factor- alpha in macrophages

By Nguyen T. D. Stechschulte A. C. Stechschulte D. J. Dileepan K. N.

Mediators of Inflammation, Vol. 7, Iss. 5, 1998-10 ,pp. : 355-361

Informa Healthcare

Access to resources Recommend Favorite